Vnitr Lek 2014, 60(4):366-374

Comparison of American and European (Czech) guidelines for diagnosis and treatment of chronic heart failure

Jindřich ©pinar1, Lenka ©pinarová2, Jiří Vítovec2, Ondřej Ludka1,*
1 Interní kardiologická klinika LF MU a FN Brno, pracoviątě Bohunice, přednosta prof. MUDr. Jindřich ©pinar, CSc., FESC
2 I. interní kardio-angiologická klinika LF MU a FN u sv. Anny Brno, přednostka prof. MUDr. Lenka ©pinarová, CSc., FESC

The new Czech and European recommendations for diagnosis and treatment of heart failure were published in 2012. The American guidelines ACCF/AHA were published in 2013. Main difference between them is presentation of acute and chronic heart failure in the European guidelines while the American and the Czech guidelines include only chronic heart failure. The American recommendations distinguish heart failure with reduced ejection fraction and with remained ejection fraction. In the beginning, the American guidelines introduce A-D classification which doesn't figure in the European neither Czech guidelines. Class A patients are ill with risk factors, but without heart failure. In contrast, class D patients are decompensated with symptoms in the rest. Epidemiologic data shows interesting results with prevalence about 0.2% in 60-69 years old subjects and 80% in subjects older than 85 years. 5 year mortality is 50%. The American guidelines start to treat class A which is in fact prevention and treatment of risk factors. There is mentioned inevitably treatment of hypertension, both systolic and diastolic which decrease risk of heart failure up to 50%. There is almost no difference in pharmacotherapy. Noteworthy, the American guidelines introduce also ACE inhibitors - fosinopril and quinapril, on the other hand beta-blockers don't involve nebivolol. Wide range of diuretics are mentioned, some of them aren't registered in the Czech Republic. European and Czech guidelines involve ivabradin. Neither nesiritid nor levosimendan for inpatients aren't involved. There is briefly mentioned surgery and cardiac mechanical support, moreover there are references for guidelines for heart transplantation.

Keywords: diagnosis; guidelines; heart failure; treatment

Received: January 20, 2014; Published: April 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©pinar J, ©pinarová L, Vítovec J, Ludka O. Comparison of American and European (Czech) guidelines for diagnosis and treatment of chronic heart failure. Vnitr Lek. 2014;60(4):366-374.
Download citation

References

  1. Hradec J, Vítovec J, ©pinar J. Summary of the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Prepared by the Czech Society of cardiology. Cor et Vasa 2013; 55(1): 33-48. Go to original source...
  2. Lewine GN, Steinke EE, Bakaeen FG et al. Sexual activity and cardiovascular disease. Circulation 2012; 125(8): 1058-1072. Go to original source... Go to PubMed...
  3. McMurray JJ, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33(14): 1787-1847. Go to PubMed...
  4. Paulus WJ, Tschope C, Sanderson JE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28(20): 2539-2550. Go to original source... Go to PubMed...
  5. Steinke EE, Jaarsma T, Baunaton SA et al. Sexual Counselling for Individuals with Cardiovascular Disease and Their Partners. Eur Heart J 2013; 34(41):3217-3235. Go to original source... Go to PubMed...
  6. ©pinar J, Vítovec J, Hradec J et al. Czech Society of Cardiology guidelines for the diagnosis and treatment of chronic heart failure 2011. Cor et Vasa 2012; 54(3-4): e114-e134. Go to original source...
  7. ©pinar J, Vítovec J, Hradec J et al. Doporučení pro diagnostiku a léčbu chronického srdečního selhání - ČKS 2011. Vnitř Lék 2012; 58(Suppl 1): S4-S40.
  8. ©pinar J, Vítovec J, Hradec J et al. Doporučení pro diagnostiku a léčbu chronického srdečního selhání - ČKS 2011. Cor et Vasa 2012; 54(3-4): 161-182. Go to original source...
  9. ©pinar J, Vítovec J, Hradec J Co je nového v evropských doporučeních pro diagnostiku a léčbu srdečního selhání. Kardiologická revue 2012; 14(3): 211-212.
  10. ©pinar J, Vítovec J: Liąí se ESC a ČKS doporučení pro diagnostiku a léčbu srdečního selhání? Kardiologická revue 2013; 15(2): 99-103.
  11. ©pinar J, Vítovec J, Hradec J et al. Srovnání doporučení pro diagnostiku a léčbu chronického srdečního selhání. Cor et vasa 2013; 55(3): 307-313. Go to original source...
  12. ©pinarová L, ©pinar J, Vítovec J. Novinky v léčbě chronického srdečního selhání - guidelines ČKS - srovnání s minulými doporučeními. Remedia 2012; 22(2): 127-131.
  13. Yanci CW, Jessup M, Bozkurt B et al. 2013 ACCF/AHA Guideline for the Management of Heart failure. JACC 2013; 62(16): e147-e239. Dostupné z DOI: <http://doi:10.1016/j.jacc.2013.05.019>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.